Pharmaceutical Advisory & Strategic Partnerships
Connecting Global Pharmaceutical Capability with Australian Market Opportunity
KAA Oceania is an Australian pharmaceutical business development and strategic partnership company specialising in the connection of accomplished international manufacturers with carefully selected opportunities across the Australian market.
Operating at the intersection of manufacturing capability, regulatory preparedness and commercial potential, KAA Oceania identifies commercially viable medicines, facilitates strategic introductions and supports the progression of pharmaceutical opportunities through licensing, supply, contract manufacturing, technology transfer and long term market development.
Portfolio Highlights
AUD 10M+
Estimated Australian Pharmaceutical Portfolio Opportunity
KAA Oceania has developed more than AUD 10 million in estimated pharmaceutical portfolio opportunity for Australian and international partners through strategic introductions, product licensing, supply arrangements and commercial development.
5 TGA Registered Products
Five pharmaceutical products introduced through KAA Oceania’s business development activities have achieved registration with the TGA: Australia’s Therapeutic Goods Administration.
18 Products in the Development Pipeline
A further 18 pharmaceutical opportunities are progressing through various stages of evaluation, commercial discussion, technical assessment, regulatory planning and market development.
Strategic Capabilities
Product Sourcing and Portfolio Development
Identification and assessment of pharmaceutical products aligned with Australian market demand, therapeutic relevance and long-term commercial potential.
Licensing and Market Development
Facilitation of licensing opportunities between international product owners and established Australian pharmaceutical companies.
Contract Manufacturing
Connection of Australian partners with capable international manufacturers for finished-dose products, specialised formulations and tailored manufacturing requirements.
Technology Transfer
Support for collaborative arrangements involving technical knowledge, manufacturing processes, product development and intellectual property.
Manufacturer Representation
Professional representation for selected international pharmaceutical manufacturers seeking credible commercial engagement within Australia and the wider Oceania region.
International Manufacturing Network
KAA Oceania maintains relationships with pharmaceutical manufacturers operating within internationally recognised regulatory and quality frameworks.
Depending upon the individual manufacturer, production facility and product category, partner credentials include approvals, registrations or compliance recognition associated with:
- TGA: Australia’s Therapeutic Goods Administration
- MHRA: United Kingdom Medicines and Healthcare products Regulatory Agency
- US FDA: United States Food and Drug Administration
- EU GMP: European Union Good Manufacturing Practice requirements
- Health Canada: Canada’s federal health authority
- German and EU NCAs: Relevant German and European Union National Competent Authorities
Across the broader manufacturing network, partners collectively maintain portfolios comprising more than 300 approved pharmaceutical products, with numerous additional programmes in development.
Selected partners have also participated in first-launch generic introductions that have contributed meaningfully to the commercial growth of Australian pharmaceutical businesses.
Product Experience
KAA Oceania’s pharmaceutical activities have included commercial opportunities involving medicines :
- Rivaroxaban
- Apixaban
- Cabergoline
- Drospirenone
- Levonorgestrel
This experience continues to expand across multiple therapeutic areas and carefully selected pharmaceutical opportunities.
More Than an Introduction. A Strategic Partnership.
Successful pharmaceutical business development requires far more than connecting a manufacturer with a prospective buyer.
It demands considered product selection, regulatory awareness, commercial judgement and a sophisticated understanding of the organisations behind each opportunity.
KAA Oceania adopts a selective, relationship-led approach, pursuing opportunities where genuine and enduring value can be created for both international manufacturing partners and Australian pharmaceutical companies.
From initial evaluation and strategic introduction to commercial negotiation and long term supply, the objective remains clear: to cultivate pharmaceutical partnerships with the capability, credibility and commercial foundation to prosper.
Explore Partnership Opportunities
For access to the pharmaceutical portfolio, manufacturing capabilities or confidential partnership discussions, contact KAA Oceania.
